Leveraging on the genomics and immunopathology of SARS-CoV-2 for vaccines development: prospects and challenges

  1. Abdullahi, I.N.
  2. Emeribe, A.U.
  3. Adekola, H.A.
  4. Abubakar, S.D.
  5. Dangana, A.
  6. Shuwa, H.A.
  7. Nwoba, S.T.
  8. Mustapha, J.O.
  9. Haruna, M.T.
  10. Olowookere, K.A.
  11. Animasaun, O.S.
  12. Ugwu, C.E.
  13. Onoja, S.O.
  14. Gadama, A.S.
  15. Mohammed, M.
  16. Daneji, I.M.
  17. Amadu, D.O.
  18. Ghamba, P.E.
  19. Onukegbe, N.B.
  20. Shehu, M.S.
  21. Isomah, C.
  22. Babayo, A.
  23. Ahmad, A.E.-F.
Zeitschrift:
Human Vaccines and Immunotherapeutics

ISSN: 2164-554X 2164-5515

Datum der Publikation: 2021

Ausgabe: 17

Nummer: 3

Seiten: 620-637

Art: Rezension

DOI: 10.1080/21645515.2020.1812313 GOOGLE SCHOLAR lock_openOpen Access editor
Institutionelles Repository: lock_openOpen Access Editor